Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

A Rare Case of Platypnea-Orthodeoxia Syndrome Developing After Atrial Fibrillation Ablation Necessitating Percutaneous Closure of the Septal Puncture Site

Presenter: Horst Sievert, Robert J. Sommer, Nadim Geloo, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Indications and Uncertainties for Atrial Fibrillation Treatment: Risk Scores, Single AF Episode, Post-CABG AF, Valvular vs. Nonvalvular, and More

Presenter: William A. Gray, Gregg W. Stone, Vivek Y. Reddy

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Atrial Fibrillation + PCI: The Myths and Realities of Triple Therapy

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Ashish Pershad

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Pharmacologic Agents to Prevent Stroke in Nonvalvular Atrial Fibrillation and PFO: Evidence and Real-world Practices

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Gregg W. Stone

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

An Introduction to the WATCH-TAVR Trial Combining TAVR and LAAC

Presenter: Amar Krishnaswamy

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

European Perspectives and Updates From a Randomized Trial Combining TAVR and LAAC

Presenter: Fabian Nietlispach

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Presenter: George D. Dangas

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

A Growing Conundrum: Coronary Access After TAVR Technical Tips and Tricks

Presenter: James B. Hermiller Jr

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to Consider CABG, Timing of PCI and TAVR, and Completeness of Revascularization)

Presenter: Torsten P. Vahl

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

The Role of MitraClip After TAVR: A Case-Based Tutorial (Who, When, and How)

Presenter: Hüseyin Ince

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Clinical Decision-Mmaking in AS and MR Patients: Choosing the Best Patients for Multivalve Interventions

Presenter: Anita Asgar

June 21, 2018

Advertisement

A Rare Case of Platypnea-Orthodeoxia Syndrome Developing After Atrial Fibrillation Ablation Necessitating Percutaneous Closure of the Septal Puncture Site

Indications and Uncertainties for Atrial Fibrillation Treatment: Risk Scores, Single AF Episode, Post-CABG AF, Valvular vs. Nonvalvular, and More

Atrial Fibrillation + PCI: The Myths and Realities of Triple Therapy

Pharmacologic Agents to Prevent Stroke in Nonvalvular Atrial Fibrillation and PFO: Evidence and Real-world Practices

An Introduction to the WATCH-TAVR Trial Combining TAVR and LAAC

European Perspectives and Updates From a Randomized Trial Combining TAVR and LAAC

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

A Growing Conundrum: Coronary Access After TAVR Technical Tips and Tricks

Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to Consider CABG, Timing of PCI and TAVR, and Completeness of Revascularization)

The Role of MitraClip After TAVR: A Case-Based Tutorial (Who, When, and How)

Clinical Decision-Mmaking in AS and MR Patients: Choosing the Best Patients for Multivalve Interventions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content